UnitedHealthcare Suspends 2025 Outlook

The company announced it is suspending its outlook for 2025 as its care services expand into a broader range of benefits products compared to the first quarter. Many Medicare Advantage beneficiaries are facing healthcare costs that are higher than anticipated, and UnitedHealth Group is projecting a return to growth in 2026.

Morningstar analyst Julie Etterback noted that challenges continue to mount. In a note to investors on Tuesday, he expressed his concerns.

“Since December, we have faced questions regarding UnitedHealth stocks,” Atterback wrote. He highlighted broader corporate-specific issues around reporting decisions, the risk evaluations of Medicare Advantage, disputes over health insurance usage, competition within the healthcare space, and spikes in health service demand.

Hemsley, at 72, has a background in accounting. He joined the company as Chief Operating Officer in 1997 and became president two years later under the leadership of the visionary CEO Dr. William McGuire, who left in 2006 amid stock pricing issues. Following McGuire’s exit, Hemsley became CEO and held the position until 2017.

Whitty, now 60, took on the role of CEO at UnitedHealth Group in 2021 and quickly appointed Thompson to lead the company’s health insurance division. Whitty, previously a top executive at GlaxoSmithKline, started his journey at UnitedHealth overseeing the Optum Division, which provides various healthcare services, including pharmacy profit management and healthcare data consulting.

During the early days of the Covid-19 pandemic, resourceful Wit stepped away from company leadership to assist with vaccine development at the World Health Organization. Upon his return as CEO, he became the public face of a challenging organization in 2024, which involved significant scrutiny from Congress regarding the handling of a cyberattack on its Change Healthcare subsidiary.